Clinical trial
NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
NCT00076492 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00076492 |
|---|---|
| Title | NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 |
| Official title | A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485 in Subjects With Early Untreated Parkinson's Disease |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | CoQ10, GPI 1485 |
| Enrollment | 195 |
| Start date | Jan 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Jan 27, 2004 |
| Last update posted | Nov 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: